Effect of sildenafil on reperfusion function, infarct size, and cyclic nucleotide levels in the isolated rat heart model

被引:50
作者
du Toit, EF
Rossouw, E
Salie, R
Opie, LH
Lochner, A
机构
[1] Univ Stellenbosch, Fac Hlth Sci, Dept Med Physiol, ZA-7505 Tygerberg, South Africa
[2] Univ Cape Town, UCT Cape Heart Ctr, ZA-7700 Rondebosch, South Africa
基金
新加坡国家研究基金会;
关键词
sildenafil; ischaemia; cyclic nucleotides; infarct size; mechanical function;
D O I
10.1007/s10557-005-6894-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have previously shown that NO-donor induced elevation in myocardial cGMP levels is associated with improved reperfusion function of the isolated rat heart. The phosphodiesterase 5 (PDE 5) inhibitor, sildenafil could potentially increase myocardial cGMP levels and thus protect the heart against ischaemic/reperfusion injury. Methods: To test our hypothesis we treated the isolated working rat heart with vehicle, OR sildenafil ( 10, 20, 50, 100, 200 nM), OR sildenafil ( 50 nM) plus a sarcolemmal (HMR 1098) or a mitochondrial (5-Hydroxydecanoate (5-HD)) K-ATP channel blocker. Hearts were then subjected to 20 min global, or 35 min regional ischaemia at 37 degrees C before reperfusion function ( aortic output, coronary flow and aortic pressure) and infarct size were documented. Pre-ischaemic, ischaemic and reperfusion myocardial cAMP and cGMP concentrations were determined. Results: Low concentrations of sildenafil ( 10, 20 and 50 nM) improved reperfusion aortic output (AO) recovery ( 61.4 +/- 4.5%, 64.8 +/- 5.2% and 62.3 +/- 5.0% vs. 45.4 +/- 3.8% for controls ( p< 0.05)) and infarct size, while high concentrations ( 200 nM) worsened AO recovery ( 24.9 +/- 4.9.0%, p< 0.05). Myocardial cGMP levels of ischaemic tissue were elevated ( 34.7 +/- 2.4 vs. 27.3 +/- 2.2 pmol/g ww) and cAMP levels were suppressed (0.59 +/- 0.03 vs. 0.87 +/- 0.06 nmol/g ww) in the sildenafil ( 50 nM) treated hearts. Co-perfusion with sildenafil plus HMR 1098 decreased AO recovery (21.7 +/- 7.6% vs. 62.3 +/- 5.0% for sildenafil alone, p< 0.05) and increased infarct size ( 29.7 +/- 2.04% vs. 8.6 +/- 2.39% for sildenafil alone, p< 0.05). Similarly, sildenafil plus 5-HD decreased reperfusion AO recovery (44.4 +/- 6.0% vs. 62.3 +/- 5.0% for sildenafil alone, p < 0.05) and increased infarct size ( 33.8 +/- 1.62% vs. 8.6 +/- 2.39% for sildenafil alone, p< 0.05). Conclusions: ( 1) Pretreatment with low concentrations of sildenafil ( 20 - 50 nM) improves, while higher concentrations ( 200 nM) worsen reperfusion function in this model. ( 2) Low concentrations of sildenafil ( 20 - 50 nM) decrease infarct size while the higher concentrations had no effect. ( 3) These protective properties of low concentrations of sildenafil may be related to its cGMP elevating and cAMP suppressing effects in the ischaemic heart. ( 4) Possible end-effectors for sildenafil in the ischaemic heart include the mitochondrial and sarcolemmal K-ATP channel.
引用
收藏
页码:23 / 31
页数:9
相关论文
共 24 条
[1]   Pharmacological activation of plasma-membrane KATP channels reduces reoxygenation-induced Ca2+ overload in cardiac myocytes via modulation of the diastolic membrane potential [J].
Baczkó, I ;
Giles, WR ;
Light, PE .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (06) :1059-1067
[2]   Nitric oxide in the penis: Physiology and pathology [J].
Burnett, AL .
JOURNAL OF UROLOGY, 1997, 157 (01) :320-324
[3]  
Conti CR, 1999, AM J CARDIOL, V83, p29C
[4]   B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening [J].
D'Souza, SP ;
Yellon, DM ;
Martin, C ;
Schulz, R ;
Heusch, G ;
Onody, A ;
Ferdinandy, P ;
Baxter, GF .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 284 (05) :H1592-H1600
[5]   Protein kinase C plays an essential role in sildenafil-induced cardioprotection in rabbits [J].
Das, A ;
Ockaili, R ;
Salloum, F ;
Kukreja, RC .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (04) :H1455-H1460
[6]  
Das S, 2002, DRUG EXP CLIN RES, V28, P213
[7]   CYCLIC-GMP IN THE PERFUSED RAT-HEART - EFFECT OF ISCHEMIA, ANOXIA AND NITRIC-OXIDE SYNTHASE INHIBITOR [J].
DEPRE, C ;
HUE, L .
FEBS LETTERS, 1994, 345 (2-3) :241-245
[8]   Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts [J].
du Toit, EF ;
McCarthy, J ;
Miyashiro, J ;
Opie, LH ;
Brunner, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (06) :1159-1167
[9]   Relation of cyclic nucleotide ratios to ischemic and reperfusion injury in nitric oxide-donor treated rat hearts [J].
Du Toit, EF ;
Meiring, J ;
Opie, LH .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 (04) :529-538
[10]  
Garlid KD, 1997, CIRC RES, V81, P1072